NLI
TEVA icon

Nippon Life Insurance’s Teva Pharmaceuticals TEVA Stock Holding History

Nippon Life Insurance’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-51,180
Closed -$1.7M – 339
2017
Q2 		$1.7M Sell
51,180
-3,530
-6% -$109K 0.03% 168
2017
Q1 		$1.76M Buy
54,710
+5,226
+11% +$178K 0.03% 166
2016
Q4 		$1.79M Buy
49,484
+1,115
+2% +$44.5K 0.04% 183
2016
Q3 		$2.23M Sell
48,369
-1,001
-2% -$52.2K 0.05% 123
2016
Q2 		$2.48M Sell
49,370
-701
-1% -$37.3K 0.06% 100
2016
Q1 		$2.68M Buy
50,071
+290
+0.6% +$17K 0.07% 97
2015
Q4 		$3.27M Sell
49,781
-445
-0.9% -$27.5K 0.08% 78
2015
Q3 		$2.84M Sell
50,226
-3,022
-6% -$196K 0.07% 91
2015
Q2 		$3.15M Sell
53,248
-2,082
-4% -$128K 0.08% 96
2015
Q1 		$3.45M Sell
55,330
-720
-1% -$41.9K 0.09% 88
2014
Q4 		$3.22M Buy
56,050
+5,733
+11% +$319K 0.08% 103
2014
Q3 		$2.71M Sell
50,317
-1,126
-2% -$59.7K 0.07% 134
2014
Q2 		$2.7M Buy
51,443
+475
+0.9% +$24.3K 0.07% 157
2014
Q1 		$2.69M Sell
50,968
-1,600
-3% -$73.9K 0.08% 145
2013
Q4 		$2.11M Sell
52,568
-6,819
-11% -$269K 0.06% 208
2013
Q3 		$2.24M Sell
59,387
-7,957
-12% -$310K 0.07% 182
2013
Q2 		$2.64M Buy
+67,344
New +$2.62M 0.09% 143

Other funds holding TEVA

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Nippon Life Insurance's TEVA Position: Q3 2017 in Review

Nippon Life Insurance sold out of Teva Pharmaceuticals (TEVA) in Q3 2017, closing a stake of 51,180 shares — an estimated $1.7M sold.

Nippon Life Insurance first reported a position in TEVA in Q2 2013 and held it in 17 quarters. The position peaked at $3.45M in Q1 2015. 535 funds tracked by Wall St. Rank hold TEVA as of Q3 2017.

  • Nippon Life Insurance reported no remaining Teva Pharmaceuticals position as of Q3 2017 after selling out during the quarter.
  • Nippon Life Insurance sold 51,180 Teva Pharmaceuticals shares in Q3 2017, an estimated $1.7M.
  • Nippon Life Insurance first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 17 quarters.
  • Nippon Life Insurance's Teva Pharmaceuticals position peaked at $3.45M in Q1 2015.
  • 535 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2017.

Based on Nippon Life Insurance's 13F filing for Q3 2017, filed 24 Oct 2017.